BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 19180563)

  • 1. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
    Liu WH; Cheng YC; Chang LS
    J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Fas and FasL in Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH cells through ROS- and Ca2+-mediated p38 MAPK activation.
    Chen KC; Kao PH; Lin SR; Chang LS
    J Cell Biochem; 2009 Jan; 106(1):93-102. PubMed ID: 19009558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Biochem; 2010 Jan; 109(1):245-54. PubMed ID: 19937732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
    Chen KC; Chiou YL; Chang LS
    J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic activity-independent pathway is involved in phospholipase A(2)-induced apoptotic death of human leukemia U937 cells via Ca(2+)-mediated p38 MAPK activation and mitochondrial depolarization.
    Liu WH; Kao PH; Chiou YL; Lin SR; Wu MJ; Chang LS
    Toxicol Lett; 2009 Mar; 185(2):102-9. PubMed ID: 19118607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notexin upregulates Fas and FasL protein expression of human neuroblastoma SK-N-SH cells through p38 MAPK/ATF-2 and JNK/c-Jun pathways.
    Chen KC; Chang LS
    Toxicon; 2010 Apr; 55(4):754-61. PubMed ID: 19944115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaphostin promotes caffeine-evoked autocrine Fas-mediated death pathway activation in Bcr/Abl-positive leukaemia cells.
    Liu WH; Chang LS
    Biochem J; 2011 Nov; 439(3):453-67. PubMed ID: 21745187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1498-506. PubMed ID: 20580678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid-induced apoptosis of human neuroblastoma SK-N-SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1.
    Chen KC; Chang LS
    Toxicology; 2009 Aug; 262(3):199-206. PubMed ID: 19540902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
    Liu WH; Chang LS
    J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
    Hsu WH; Hsieh YS; Kuo HC; Teng CY; Huang HI; Wang CJ; Yang SF; Liou YS; Kuo WH
    Arch Toxicol; 2007 Oct; 81(10):719-28. PubMed ID: 17673978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.
    Chen YJ; Wang JJ; Chang LS
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytotoxin isolated from Agkistrodon acutus snake venom induces apoptosis via Fas pathway in A549 cells.
    Zhang L; Cui L
    Toxicol In Vitro; 2007 Sep; 21(6):1095-103. PubMed ID: 17544616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of p38 MAPK- and JNK-modulated expression of Bcl-2 and Bax in Naja nigricollis CMS-9-induced apoptosis of human leukemia K562 cells.
    Chen YJ; Liu WH; Kao PH; Wang JJ; Chang LS
    Toxicon; 2010 Jun; 55(7):1306-16. PubMed ID: 20144638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH; Lee SJ
    J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine.
    Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ
    Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways.
    Wang Y; He QY; Che CM; Tsao SW; Sun RW; Chiu JF
    Biochem Pharmacol; 2008 Mar; 75(6):1282-91. PubMed ID: 18241839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.